FDA approves Bayer's Ultravist® (iopromide) injection f

WHIPPANY, N.J.--(BUSINESS WIRE)--Jun 23, 2023--

Related Keywords

United States , Hannah Perry , Williamf Sensakovic , Kimeyaf Ghaderi , Parisa Lotfi , Tejass Mehta , Marcbi Lobbes , Konstanze Diefenbach , Susang Koman , Maxines Jochelson , Jordana Phillips , Drug Administration , Head Of Radiology Research , Facebook , World Health Organization , Twitter , Radiology Research , Magnetic Resonance Imaging , Injection System , Contrast Computed Tomography , Full Prescribing , Intrathecal Use , Kidney Injury , Adverse Reactions , Injection Site Reactions , Pediatric Patients , Cell Crisis , Sickle Cell Disease , Cutaneous Adverse Reactions , Laboratory Tests , Important Information , Hypersensitivity Reactions , Malignant Disease , Significant Arterial Stenosis , Contrast Enhanced Mammography , Current Applications , Breast Density , Updated April , Breast Cancer Fact , Updated March , Business Wire ,